Senators question Chamber of Commerce’s motives around march-in rights

Sens. Eliz­a­beth War­ren (D-MA), Bernie Sanders (I-VT) and Jeff Merkley (D-OR) ac­cused a new US Cham­ber of Com­merce coali­tion of at­tempt­ing to “stymie the White House’s drug pric­ing ini­tia­tives.”

The Busi­ness Al­liance to Stop In­no­va­tion Con­fis­ca­tion (BA­SIC) Coali­tion launched in March to “counter emerg­ing pol­i­cy threats to U.S. in­no­va­tion from ex­ces­sive gov­ern­ment over­reach.” One of its tar­gets is a White House pro­pos­al around the use of “march-in rights” on high-priced drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.